Learn More
Invitrogen™ VEGF-165 Polyclonal Antibody

Goat Polyclonal Antibody
Supplier: Invitrogen™ PA547103
Description
In Western blots, less than 2% cross-reactivity with recombinant human VEGF165, recombinant mouse VEGF164, and recombinant rat VEGF164 (under non-reducing conditions) is observed. Reconstitute at 0.2 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
The vascular endothelial growth factor (VEGF) family currently includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, and PIGF. VEGF and its receptor system have been shown to be the fundamental regulators in the cell signaling of angiogenesis. Most tumors have the absolute requirement of angiogenesis and VEGF has been described as the most potent angiogenic cytokine linked to this process. To date 5 different isoforms of VEGF have been described. These isoforms are generated as the result of alternative splicing from a single VEGF gene. These various isoforms have been shown to bind to two tyrosine-kinase receptors flt-1 (VEGFR-1) and flk-1/KDR (VEGFR-2), which have been found to be expressed almost exclusively on endothelial cells.
Specifications
VEGF-165 | |
Polyclonal | |
Unconjugated | |
vegfaa | |
H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF | |
Goat | |
Antigen Affinity Chromatography | |
RUO | |
30682 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Lyophilized |
Neutralization, Western Blot | |
0.2 mg/mL | |
PBS with 5% trehalose and No Preservative | |
O73682 | |
VEGFAA | |
Sf 21-derived recombinant zebrafish VEGF165 Ala24-Arg188. | |
100 μg | |
Primary | |
Zebrafish | |
Antibody | |
IgG |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.